Mammoleptin (Capsules) Instructions for Use
Marketing Authorization Holder
Herbapex Pharmaceutical (Group), Co. Ltd (China)
ATC Code
G02CX (Other drugs used in gynecology)
Dosage Form
| Mammoleptin | Capsules: 60 pcs. |
Dosage Form, Packaging, and Composition
| Capsules | 1 caps. |
| Deer antler velvet powder | 89.1 mg |
| Powder of Scrophularia ningpoensis root | 59.4 mg |
| False ginseng root powder | 59.4 mg |
| Dry extract powder of a mixture of plant raw materials* | 112.1 mg |
*- to obtain 112.1 mg of the mixture, 792.7 mg of a mixture of raw materials is used: Trichosanthes kirilowii root, Trichosanthes rosthornii 27.8 mg, Paeonia lactiflora root, Paeonia veitchii 17.8 mg, Auklandia lappa root -47.5 mg, Forsythia suspensa fruit – 23.8 mg, Mongolian dandelion aerial part – 59.4 mg, Spatholobus stem – 59.4 mg, dried Sargassum seaweed – 115.8 mg, Carthamus tinctorius buds – 35.6 mg, Laminaria japonica thallus -231.5 mg, Echinops dahuricus root – 35.6 mg, Paeonia suffruticosa root 83.1 mg, Prunella vulgaris spike – 59.4 mg
60 pcs. – plastic bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Drug used for diseases of the mammary glands
Pharmacotherapeutic Group
Remedy for the treatment of mastopathy of plant origin
Pharmacological Action
A combined herbal preparation, the pharmacological action of which is due to the combined properties of its constituent components.
It has anti-inflammatory, anti-edematous, analgesic action.
Course use of the drug helps to reduce the intensity and disappearance of pain syndrome, which is accompanied by the regression of structural changes in the breast tissue caused by diffuse fibrocystic mastopathy.
Indications
Use this medication exclusively for the treatment of specific benign breast conditions as determined by a healthcare professional.
- Mastalgia;
- Diffuse fibrocystic mastopathy.
It is intended for the management of pain and structural changes associated with these diagnoses.
ICD codes
| ICD-10 code | Indication |
| N60 | Benign mammary dysplasia (including fibrocystic mastopathy) |
| N64.4 | Mastodynia |
| ICD-11 code | Indication |
| GB20.Z | Benign breast disease, unspecified |
| GB23.5 | Mastodynia |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the capsules orally. The standard adult dosage is 5 capsules taken three times daily.
Ingest the dose 30 to 60 minutes after a meal to ensure optimal absorption and minimize potential gastrointestinal discomfort.
The typical treatment course lasts for 2 months. Any decision to extend the duration or initiate a repeat course of therapy must be made by the attending physician based on clinical evaluation.
Adverse Reactions
Monitor for potential adverse effects during treatment. Allergic reactions are possible and may manifest as skin rash, itching, or urticaria.
In rare instances, patients may experience transient gastrointestinal disturbances, including short-term pressing pain in the epigastric region, heartburn, belching, or dry mouth.
Discontinue use and seek medical advice if any severe or persistent adverse reactions occur.
Contraindications
Do not administer this drug under any circumstances to patients with specific conditions or characteristics due to the potential for harm.
- Pregnancy;
- Lactation period;
- Age under 18 years;
- Hypersensitivity to the components of the drug.
The safety and efficacy in these populations have not been established, and use is strictly prohibited.
Drug Interactions
Be aware that formal interaction studies with other medications have not been conducted.
Due to the complex herbal composition, exercise caution when co-administering with other drugs, as pharmacodynamic or pharmacokinetic interactions cannot be ruled out.
Inform your healthcare provider about all concomitant medications, including prescription, over-the-counter, and herbal products.
Overdose
Manage suspected overdose with immediate supportive measures. There is no specific antidote for this herbal preparation.
Symptoms of overdose may be an exaggeration of the known adverse reactions, particularly severe gastrointestinal distress such as persistent epigastric pain, nausea, or vomiting.
In case of overdose, discontinue the medication immediately and initiate symptomatic and supportive treatment. Contact a poison control center or physician for further management guidance.
Use in Pregnancy and Lactation
Contraindicated during pregnancy and lactation.
Pediatric Use
Contraindicated under 18 years of age.
Special Precautions
The drug should be taken after prescription and under medical supervision.
Storage Conditions
Store the drug at a temperature not exceeding 25°C (77°F), in a dry place, protected from light. Keep out of reach of children.
Shelf Life
Shelf life – 3 years.
Do not use after the expiration date printed on the packaging.
Dispensing Status
The drug is approved for use as an over-the-counter remedy.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
OKI, sachets 80mg 2g, 12pcs 